Burcombe, R. J., Makris, A., Richman, P. I., Daley, F. M., Noble, S., Pittam, M., . . . Wilson, G. D. (2005). Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer, 92(1), 147. https://doi.org/10.1038/sj.bjc.6602256
Chicago Style (17th ed.) CitationBurcombe, R. J., et al. "Evaluation of ER, PgR, HER-2 and Ki-67 as Predictors of Response to Neoadjuvant Anthracycline Chemotherapy for Operable Breast Cancer." British Journal of Cancer 92, no. 1 (2005): 147. https://doi.org/10.1038/sj.bjc.6602256.
MLA (9th ed.) CitationBurcombe, R. J., et al. "Evaluation of ER, PgR, HER-2 and Ki-67 as Predictors of Response to Neoadjuvant Anthracycline Chemotherapy for Operable Breast Cancer." British Journal of Cancer, vol. 92, no. 1, 2005, p. 147, https://doi.org/10.1038/sj.bjc.6602256.